Genome & Company Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun '24 Jun 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Cash & Equivalents	72,420	56,356	72,216	36,049	103,948	21,938
Short-Term Investments	6,765	18,863	28,205	35,249	5,640	3,686
Trading Asset Securities	5,195	11,053	6,278	5,865	-	5,000
Cash & Short-Term Investments	84,380	86,272	106,699	77,164	109,588	30,624
Cash Growth	-21.61%	-19.14%	38.28%	-29.59%	257.85%	-
Accounts Receivable	1,168	1,402	1,957	759.22	-	-
Other Receivables	1,067	1,544	864.23	992.14	1,377	356.06
Receivables	2,236	2,946	2,821	1,751	1,377	356.06
Inventory	5,075	3,568	2,238	1,327	-	-
Prepaid Expenses	714.24	1,150	1,159	1,102	243.77	125.24
Other Current Assets	1,083	3,114	3,994	433.15	71.28	371.48
Total Current Assets	93,488	97,050	116,909	81,777	111,280	31,477
Property, Plant & Equipment	36,166	34,624	21,526	16,475	4,271	2,926
Long-Term Investments	-	-	-	-	-	-0
Goodwill	14,133	14,133	16,458	16,458	1,063	-
Other Intangible Assets	9,654	11,102	13,921	18,388	3,811	329.5
Other Long-Term Assets	4,756	5,152	4,182	4,119	457.17	452.65
Total Assets	158,197	162,060	172,997	137,216	120,883	35,185
Accounts Payable	1,004	340.19	205.18	321.4	-	-
Accrued Expenses	2,462	2,723	3,428	1,713	316.7	656.33
Short-Term Debt	12,805	11,997	-	-	-	-
Current Portion of Leases	1,078	1,055	2,024	1,583	580.26	417.76
Other Current Liabilities	7,560	12,116	5,484	6,208	2,111	64,986
Total Current Liabilities	24,909	28,231	11,141	9,826	3,008	66,060
Long-Term Debt	10,384	9,637	-	-	-	5,850
Long-Term Leases	3,441	3,764	4,267	5,243	1,179	1,132
Long-Term Deferred Tax Liabilities	4,186	4,414	5,582	6,826	782.66	-
Other Long-Term Liabilities	2,793	2,497	1,462	1,921	830.66	114.36
Total Liabilities	45,712	48,543	22,452	23,816	5,800	73,156
Common Stock	7,643	7,363	7,046	7,033	6,652	4,113
Additional Paid-In Capital	304,688	304,765	304,724	257,345	246,880	73,810
Retained Earnings	-291,196	-284,659	-237,193	-185,355	-151,238	-120,505
Comprensive Income & Other	37,285	34,240	21,784	13,710	9,139	2,906
Total Common Equity	58,420	61,708	96,360	92,733	111,434	-39,676
Minority Interest	53,541	51,089	53,248	20,667	3,371	-
Shareholders' Equity	112,485	113,517	150,544	113,400	115,083	-37,971
Total Liabilities & Equity	158,197	162,060	172,997	137,216	120,883	35,185
Total Debt	27,708	26,453	6,291	6,826	1,759	7,399
Net Cash (Debt)	56,672	59,819	100,408	70,338	107,829	23,225
Net Cash Growth	-41.34%	-40.42%	42.75%	-34.77%	364.28%	-
Net Cash Per Share	1972.81	2118.26	3566.88	2616.46	5599.59	1448.66
Filing Date Shares Outstanding	15.19	29.45	28.18	28.13	26.61	16.03
Total Common Shares Outstanding	15.19	29.45	28.18	28.13	26.61	16.03
Working Capital	68,580	68,819	105,769	71,952	108,272	-34,584
Book Value Per Share	3846.34	2095.34	3419.08	3296.30	4187.69	-2474.79
Tangible Book Value	34,633	36,473	65,981	57,888	106,559	-40,005
Tangible Book Value Per Share	2280.23	1238.47	2341.16	2057.68	4004.50	-2495.34
Land	2,711	2,710	10.59	-	-	-
Buildings	9,251	9,220	-	-	-	-
Machinery	17,599	15,838	14,662	9,167	3,026	1,498
Construction In Progress	9,333	8,492	4,245	2,262	19.45	350

Source: S&P Capital IQ. Standard template. Financial Sources.